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ABSTRACT
DNA polymerase m (Pol m) is a DNA-dependent DNA
polymerase closely related to terminal deoxynucleo-
tidyl transferase (TdT), and prone to induce template/
primer misalignments and misincorporation. In addi-
tion to a proposed general role in non-homologous
end joining of double-strand breaks, its mutagenic
potential and preferential expression in secondary
lymphoid tissues support a role in somatic hypermu-
tation (SHM)of immunoglobulingenes. Here, weshow
that human Pol m protein is expressed in the nucleus
of centroblasts obtained from human tonsils, forming
a characteristic foci pattern resembling that of other
DNA repair proteins in response to DNA damage.
Overexpression of human Pol m in Ramos cells, in
which the SHM process is constitutive, augmented
the somatic mutations specifically at the variable
(V) region of the immunoglobulin genes. The nature
of the mutations introduced, mostly base substitu-
tions, supports the contribution of Pol m to mutation
of G and C residues during SHM. In vitro analysis of
Pol m misincorporation on specific templates, that
mimic DNA repair intermediates and correspond to
mutational hotspots, indicated that many of the muta-
tions observed in vivo can be explained by the capa-
city of Pol m to induce transient template/primer
misalignments.
INTRODUCTION
The primary repertoire of antibody specificities is created in
the bone marrow by a DNA rearrangement process involving
immunoglobulin (Ig) V (variable), D (diversity) and J (joining)
gene segments (1). Following antigen encounter, germinal
center (GC)-B cells (centroblasts) proliferate rapidly and
undergo a further round of diversification through the somatic
hypermutation (SHM) process. In SHM, a large number of
mutations (103–104 mutations/bp/generation) are intro-
duced specifically in rearranged IgV genes [reviewed in
(2)]. Most mutations consist of single-nucleotide substitutions,
although deletions and insertions also occur. Ig gene hyper-
mutation exhibits a distinctive nucleotide misincorporation
pattern, favoring transitions over transversions (3) and prefer-
entially targeting G/C residues (4,5). Moreover, extensive
sequence analyses have defined the consensus sequences
RGYW and WA (most mutable nucleotide underlined; R is
purine, Y is pyrimidine and W is A or T) as highly mutable
DNA sequence motifs (6,7).
Dissection of the SHM process has yielded clear clues as to
cis-acting factors [reviewed in (8)], but the molecular mechan-
ism remains to be elucidated. At present, activation-induced
cytidine deaminase (AID) is the only enzymatic activity found
to be indispensable for SHM (9,10). Although initially des-
cribed as an RNA editing enzyme (11), AID is also reported
to deaminate dC residues directly on DNA (12–15). Recent
data suggest that DNA strand breaks could trigger SHM
(16–20), and it seems very likely that generation of these
DNA breaks, defining the SHM hotspots, is closely related
to AID activity (21–23). The ‘DNA deamination’ model pro-
poses that AID deaminates deoxycytidine residues to uracil
directly on DNA at the hypermutation domain (24); this would
generate mismatches that, in the course of DNA repair, would
originate the DNA breaks. Other recent work suggests the
existence of AID-independent mechanisms for DNA break
generation (25–28). Independently of the way in which these
breaks are generated (as nicks and/or double-strand breaks,
DSBs), most SHM models suggest that they trigger the
mechanism(s) underlying somatic mutation. This invokes
the involvement of an error-prone ‘DNA break repair’ process
at the heart of the mutasome (29), which would include parti-
cipation of DNA polymerase(s) and nucleolytic activities
[reviewed in (30)].
The mammalian DNA polymerase family has grown
considerably in the last three years, and we currently know
that human cells encode at least 13 template-dependent
DNA polymerases, several with clear error-prone activity
(31–33). Initial analyses discarded the direct involvement of
terminal deoxynucleotidyl transferase (TdT) (34) and DNA
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polymerase b (35) in SHM. Novel candidates for the muta-
genic DNA polymerase activity (Pols i, k, h, z and m) have
thus emerged [reviewed in (30)]. Convincing data indicate
that Pol h is an A/T mutator in the SHM process (7,36), and
that inhibition of Pol z expression results in reduced SHM
frequency (37,38). The participation of Pol i in SHM is unclear
since induction of SHM in BL2 cells is dependent on Pol i
(39), but Pol i knockout mice show no significant alteration in
this process (40). A putative role for Pol k in SHM is not
supported by the analysis of its KO model (41,42). In any case,
these data suggest that more than one error-prone DNA poly-
merase is involved in process (29,30,43).
Human DNA polymerase m (Pol m) was the first identified
novel member of the mammalian DNA Pol X family, showing
both amino acid sequence and functional domain organization
closely related to TdT (44). Although various biological roles
were proposed for Pol m (45), they are still matter of specula-
tion. Based on the in vitro polymerization properties of highly
purified human Pol m, which shows unprecedented error-prone
DNA synthesis on template-primer structures, and preferential
mRNA expression in secondary lymphoid organs, Pol m was
suggested to be involved in SHM of Ig genes (44,45). Pol m
was recently reported to have a unique ability to promote
microhomology-mediated template-primer realignments
(46), to be up-regulated in response to ionizing radiation-
induced DNA DSBs, and to form complexes with Ku 70/80
and XRCC4/DNA ligase IV heterodimeric complexes in the
presence of DNA (47). These data support a role for Pol m in
the non-homologous end joining pathway for DSBs repair.
Analysis of Pol m-deficient mice did not support a putative
role for Pol m in SHM (48), but showed a mild impairment of
Ig gene rearrangement (49), supporting a previously suggested
role for Pol m in V(D)J recombination (45).
Here, we show that human Pol m is preferentially expressed
in GC-B cells, forming discrete nuclear foci that resemble
DNA damage-induced DNA repair factories. Overexpression
of human Pol m in a Burkitt’s lymphoma-derived B cell line
(Ramos), in which SHM is constitutive, induced an increase in
somatic mutations specifically targeted to G/C residues in IgV
genes. In vitro analyses using DNA substrates corresponding
to hotspot sequences also support the ability of Pol m to gen-
erate these mutations. These data support a potential role for
Pol m in the highly error-prone DNA synthesis events that
appear to be associated to SHM.
MATERIALS AND METHODS
Cell lines and culture conditions
Ramos cells were kindly provided by Dr Martinez-A
(CNB, Madrid) and were maintained in RPMI 1640 medium
(BioWhittaker) supplemented with 10% fetal calf serum
(FCS) (Gibco-BRL), 2 mM L-glutamine (BioWhittaker),
HEPES buffer (10 mM, BioWhittaker) and gentamycin
(50 mg/ml, BioWhittaker). The cell cultures were maintained
in a humidified 37C incubator with 5% CO2.
Rabbit antiserum preparation and testing
Recombinant purified human Pol m was obtained as described
previously (39). Outbred New Zealand rabbits received
intradermal injections in multiple sites using 100 mg of pur-
ified protein emulsified with an equal volume of Freund’s
complete adjuvant (two times). Two intramuscular boosts
of 100 mg of the same material in incomplete adjuvant
were given 4 and 7 weeks later. Sera were collected 7 and
10 days after the last injection, and tested by enzyme-linked
immunosorbent assay.
Western blotting
The cells (2 · 106) were lysed in 100 ml of RIPA buffer
(137 mM NaCl, 20 mM Tris–HCl, pH 8, 1 mM MgCl2, 1 mM
CaCl2, 10% glycerol, 1% NP-40, 0.5% deoxycholate, 0.1%
SDS, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mM phenyl-
methylsulfonyl fluoride and 1 mg/ml aprotinin) for 30 min at
4C and debris removed by centrifugation (18 000 g, 20 min).
Protein concentration was determined using the Dc protein
assay (Bio-Rad). Protein (20 mg) was separated in 10%
SDS–PAGE and transferred to nitrocellulose membranes
(Bio-Rad). Membranes were blocked for 1 h in Tris-buffered
saline (25 mM Tris) with 5% non-fat dry milk (blocking buf-
fer), followed by incubation with primary (2 h) and secondary
antibody (40 min). Western blots were developed using the
enhanced chemiluminescence system (Amersham Bios-
ciences). Rabbit polyclonal anti-hPol m antibody was used
at 1:1000 dilution in blocking buffer.
Immunohistochemistry
Immunohistochemical analysis of human tonsils was per-
formed on paraffin-embedded tissue sections. After incubation
with the primary antibody (anti-human Pol m, 1:200 dilution),
immunodetection was performed with biotinylated anti-rabbit
immunoglobulins, followed by peroxidase-labeled streptavidin
and with diaminobenzidine chromogen as substrate. Immuno-
staining was performed using the TechMate 500 (DAKO)
automatic immunostaining device. The labeling system and
secondary antibodies were all obtained from DAKO.
Immunofluorescence microscopy
The cells were fixed in 4% paraformaldehyde (10 min, room
temperature), then washed three times in PBST (PBS contain-
ing 0.1% Tween). Preparations were incubated with 20% FCS
(1 h, room temperature), followed by 1 h incubation with
primary antibody. After washing with PBST and staining
with secondary antibody (40 min), preparations were washed
and mounted in ProLong Antifade mounting medium
(Molecular Probes). Rabbit anti-hPol m antibody was used
at 1:200 dilution in PBS.
Retroviral transduction and generation of Ramos
cell clones overexpressing human Pol m
Human Pol m full-length cDNA was subcloned into the XhoI–
EcoRI sites of plasmid pLZR2-IRES/gfp. This vector was
derived from the retroviral transfer construct pLZR-CMV-
gfp (50) by replacing the enhanced green fluorescent protein
(EGFP) gene with the bicistronic cassette internal ribosomal
entry site (IRES)-EGFP from pIRES2-EGFP (Clontech),
preceded by a synthetic multicloning site (51). The resulting
retroviral vector, confirmed by sequencing and transient
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expression analysis, was denominated pLZR2-hPol m-IRES/
gfp. High-titer retroviral supernatants (>5 · 106 iu/ml) were
produced by transient transfection of 293T cells as described
previously (50), and Ramos cells were transduced using these
supernatants as described for peripheral B lymphocytes
(PBLs) (50). Four days post-infection, gfp+high cells (>97%
purity) were obtained by fluorescence-activated cell sorting in
EPICS Elite sorter equipment. Parental Ramos cells and those
transduced with either the control vector (pLZR2-IRES/gfp) or
the hPol m-encoding vector (pLZR2-hPol m-IRES/gfp) were
seeded by limiting dilution in 96 well plates. Several indivi-
dual clones were maintained in culture for 3 months at a cell
concentration of 106 cells/ml. Each clone was then tested for
Pol m expression by western blot analysis using rabbit anti-
hPol m antibodies. Clones showing different Pol m expression
levels, as well as control clones from both parental and empty
vector-transduced cells, were selected for further molecular
analysis.
Amplification of rearranged VH and Cm regions from
Ramos genomic DNA
Genomic DNA from parental and transduced Ramos cells was
isolated using Tri-Reagent (Sigma) according to manufac-
turer’s instructions. The Ramos VH region was amplified
using Pfu DNA polymerase (Promega). For PCR amplifica-
tion, we used an upstream primer that hybridizes at the VH4–
34 gene [VH4bS, d(CAGGTGCAGCTACAGCAG)] and a
downstream primer that hybridizes in the JH6 region
[JhAS, d(GCTGAGG AGACGGTGACC)] (52). The reactions
were performed in 10 ml vol containing 1· Pfu buffer
(Promega), 200 mM each dATP, dGTP, dCTP and dTTP
(GibcoBRL), 1 mM each primer and 0.6 U of Pfu DNA
polymerase. The enzyme was added after a first denaturation
step (5 min at 80C) to avoid non-specific PCR products. The
amplification program consisted of 30 cycles of 20 s at 95C,
20 s at 53C and 40 s at 72C, followed by a final incubation
step at 72C for 10 min. The genomic Cm 1/2 region was
amplified using primers C1mS [d(GGACTTCCTTCCCGAC-
TCCAT)] and C2mAS [d(ACGAAGACGCTCACTTTGG-
GA)], which hybridize at exons 1 and 2 of the Cm heavy
chain gene, respectively. Amplification was as above, except
that a 60C annealing temperature was used. The PCR pro-
ducts were blunt-end ligated into EcoRV-digested pZErO
plasmid (Invitrogen). Following transformation in competent
DH5a Escherichia coli cells and screening, positive colonies
were picked and plasmid mini-preparations were made. Plas-
mids were sequenced in both directions using the ABIPrism
BigDye Terminator cycle sequencing kit (Perkin Elmer) and
automatic sequencing on an ABIPrism377 DNA sequencer XL
Upgrade (Applied Biosystems/Perkin Elmer). Sequence ana-
lysis was performed using the program Multalin (http://www.
toulouse.inra.fr/multalin.html) and the VBASE-database
(http://www.mrc-cpe.cam.ac.uk/imt-doc/restricted/ok.html).
In vitro DNA polymerization assays on
defined DNA molecules
Human Pol m DNA polymerase activity was evaluated in vitro
using 50-labeled template-primer molecules as substrates,
which were prepared by hybridization of synthetic
oligonucleotides. All oligonucleotides were obtained from
Invitrogen-Life Technologies and were purified by electro-
phoresis on 8 M urea/20% polyacrylamide gels. Oligonucleo-
tide primers p66 [d(GTAGTAACCACTGAA)], p74
[d(GTGGGTCCTTCAGTG)], p156 [d(50GAGGGACGG-
GTTGTA)], p193 [d(TCTTGGACGTGTCTA)], p210
[d(CTTCAGGGAGAGCTG)] and p218 [d(GAGCTCAAC
TTCAGG)] were 50-labeled with [g-32P]ATP and T4 polynu-
cleotide kinase. These 50-32P end-labeled oligonucleotide pri-
mers were then hybridized, in the presence of 0.2 M NaCl and
60 mM Tris–HCl (pH 7.5), to the corresponding template
oligonucleotides t66 [d(GGGTCCTTCAGTGGTTACTAC)],
t74 [d(CCAGCTCCAGTAGTAACCACTGAAGGACC-
CAC)], t156 [d(ACCAACTACAACCCGTCCCTC)], t193
[d(TCGAGTCACCATATCAGTAGACACGTCCAAGA)],
t210 [d(AAGAAGCAGCTCTCCCTGAAG)], and t218
[d(GCTCTCCCTGAAGTTGAGCTC)], to generate the
template-primer molecules corresponding to positions 66, 74,
156, 193, 210 and 218 of the IgVH4–34 gene, respectively.
DNA substrates, p74c-gap2 and p74c-gap1, were obtained by
hybridization of 50-32P end-labeled oligonucleotide primer
p74 with the template oligonucleotide t74 and the downstream
oligonucleotides d74g2 [d(TACTACTGGAGCTGG)] and
d74g1[d(TTACTACTGGAGCTGG)], respectively.DNAsub-
strates, p193-gap2 and p193-gap1, were obtained by hybrid-
ization of 50-32P end-labeled oligonucleotide primer p193 with
the template oligonucleotide t193 and downstream oligonu-
cleotides d193g2 [d(GATATGGTGACTCGA)] and d193g1
[d(TGATATGGTGACTCGA)], respectively. Polymerization
reactions were carried out in a 12.5 ml vol in 50 mM Tris–HCl
(pH 7.5), 2 mM MgCl2, 1 mM DTT, 4% glycerol, 0.1 mg/ml
BSA, 4 nM of 50-labeled substrate, 100 nM of purified human
Pol m and the indicated concentration of dNTPs. After incuba-
tion (30 min at 30C), the reactions were terminated by adding
gel loading buffer [95% (v/v) formamide, 10 mM EDTA, 0.1%
(w/v) xylene cyanol and 0.1% (w/v) bromophenol blue]. Sam-
ples were heat-denatured (95C for 5 min) before loading onto
the gel; the products were resolved and analyzed in denaturing
8 M urea/20% PAGE and autoradiography.
RESULTS
Human Pol m is expressed in GC-B cells (centroblasts)
and forms foci-like structures
Human Pol m mRNA is preferentially expressed in lymphoid
secondary organs (44). To determine whether human Pol m
mRNA levels correlate with the amount of Pol m protein, we
generated a rabbit antibody using highly purified E.coli-
expressed human Pol m (see Materials and Methods). The
IgG fraction (anti-Pol m) was obtained and used to evaluate
Pol m levels in human GCs. Immunohistochemical analysis of
human tonsil-derived secondary follicles, visualized by B220
marker staining (blue), showed a positive Pol m signal (brown)
in GCs, as shown in the magnification of an individual follicle
(Figure 1A). The Pol m-positive signal in GC-B cells was
clearly intracellular (Figure 1C). Specificity was confirmed,
as pre-incubation of anti-Pol m IgG with purified recombinant
human Pol m greatly diminished staining; this pattern was not
observed after incubation with anti-Pol l antibody (data not
shown).
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To further evaluate the cellular distribution of Pol m in
GC-B cells, we analyzed the expression in purified human
centroblasts (B220+PNA+ tonsil B cells) using indirect
immunofluorescence. Pol m showed nuclear localization
(Figure 1D), distributed in discrete spots resembling the
foci in which the cellular DNA repair machinery co-localizes
after the induction of DNA damage (53–55). This expression
pattern was specific, as it was not found in control peripheral
B cells (see Figure 1B) or when a control IgG fraction was
used in the same conditions (data not shown). This protein
distribution is similar to that reported for Pol m after DSB
induction in a human cell line (47). Pol m expression data
are thus consistent with a putative contribution of Pol m in
IgV gene SHM (44,45), a process that occurs specifically in
the GC centroblast nucleus.
Human Pol m overexpression in a B cell line with
constitutive SHM
The Ramos cell line is characterized as an IgM-expressing
Burkitt’s lymphoma line that shows a high rate of constitu-
tive IgV diversification during standard in vitro culture (16).
Since Ramos VH diversification shows the major hallmarks
of Ig gene hypermutation, this cell line is considered a good
in vivo model for SHM analysis. The functional conse-
quences of human Pol m overexpression in Ramos cells
were evaluated after retroviral transduction with human
Pol m cDNA (see Materials and Methods). Construction of
empty and human Pol m-cloned retroviral vectors, infection
and clonal selection of either parental or transduced Ramos
cells, were as described in Materials and Methods. As shown
in Figure 2A, western blot analysis of two of the selected
clones (P1 and P2) showed a marked overexpression of
human Pol m (8- and 59-fold, respectively) relative to the
levels in control (empty vector-transduced) clones C1 and
C2, and parental Ramos clones (data not shown). Indirect
immunofluorescence analysis of clone C2 cells using anti-
Pol m (Figure 2B) showed endogenous Pol m, levels as for
Ramos cells, distributed in foci-like structures similar to those
described in GC-B cells (Figure 1D). Ramos and clone C2
cells showed this pattern in equivalent proportions (5–
10%). In contrast, a large proportion (>85%) of P2 clone
cells presented a more pronounced and intense foci
(Figure 2B), in good agreement with its 59-fold higher
expression of Pol m. No positive signal was detected either
in Ramos cells or in clone C2 or P2 cells when pre-immune
Figure 1. Human Pol m is expressed preferentially in GC-B cells forming nuclear foci. (A) Representative image of an individual GC from human tonsil sections,
stained with naive B cell marker B220 (blue) and with anti-human Pol m antibody (brown). (C) Amplified image of a GC, in which GC-B cells show intracellular
human Pol m expression (brown). (B and D) Immunofluorescence analysis of human Pol m expression in purified peripheral B lymphocytes (B) versus human tonsil-
derived centroblasts (D). Cells were incubated with rabbit anti-human Pol m antibody (1:200 dilution), followed by fluorescein isothiocyanate-anti-rabbit secondary
antibody, as described in Materials and Methods.
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antiserum was used for analyses (Figure 2B). These results
clearly indicated that Pol m can be overexpressed in the
Ramos cell line with no major alteration in viability, and
that the excess protein accumulates in the natural nuclear
reservoirs, forming foci-like structures.
Human Pol m overexpression in Ramos cell line
promotes an increase in the somatic mutation rate
To evaluate the putative implication of Pol m in the hypermu-
tation mechanism, we analyzed whether human Pol m over-
expression affected the final products of the SHM process.
At 3.5 months post-transduction, genomic DNA was prepared
from selected clones corresponding to either the parental or
transduced Ramos cell line, all cultured in parallel, and Ig
locus VH and Cm regions were amplified specifically by
PCR (Materials and Methods). The cloned PCR products
were fully sequenced for a total of 206 clones, 184 correspond-
ing to VH 4–34 Ig gene and 22 corresponding to the Cm region.
VH diversification in Pol m-overexpressing Ramos cells was
not influenced by a general mutator phenotype, since muta-
tions did not occur in Cm regions (data not shown). A database
was created for specific mutational events that included muta-
tions detected in 82 sequences from both the parental Ramos
Figure 2. Human Pol m overexpression in Ramos cells. (A) Western blot analysis of individual Ramos clones retrovirally transduced with the pLZR-IRES/gfp (C1,
C2) and pLZR2-Pol m-IRES/gfp (P1, P2) vectors (see Material and Methods). All cell lysates were normalized for total protein amount (20 mg loaded per lane).
Recombinant human Polm (10 ng) was used as a positive control. (B) Indirect immunofluorescence analysis of human Polm overexpression in Ramos cell clones. The
figure shows representative fields for control clone C2 (left panels) and Pol m-overproducing clone P2 (right panels), which were incubated with anti-Pol m IgGs
(bottom panels) or pre-immune antiserum (upper panels). The EGFP marker used throughout the retroviral transduction process and subsequent clone selection is
indicated by the green background present in all cells. The cells were incubated with rabbit anti-human Pol m antibody (1:200 dilution), followed by rhodamine-anti-
rabbit secondary antibody (red; see Materials and Methods).
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cells and from the vector-transduced clones (collectively
referred to as control Ramos), and those in 102 sequences
from Pol m-overproducing clones. Mutations were defined
by comparison with the canonical VH sequence from the par-
ental Ramos cell line (GenBank sequence AY786364). The
mutational database was created after the sequences (muta-
tions) had been evaluated for phylogenetic relationships, to
avoid multiple iteration of a specific mutation. The composite
database consisted of 184 distinct, unselected mutated/unmu-
tated VH sequences, covering 27.962 and 34.782 bp for control
and Pol m-overexpressing Ramos cells, respectively (Table 1).
Data analysis indicated that average mutation frequency in Pol
m-overexpressing Ramos subclones increased by 290%
(3.2 · 103 mutations/base) compared to control Ramos
cells (1.1 · 103 mutations/base). Excess human Pol m
appeared to be integrated physiologically in the SHM machin-
ery, as it specifically increased the mutation rate but did not
induce a high frequency loss of cell surface-expressed IgM
(data not shown), at difference from overexpression of TdT
(16), the closest DNA polymerase relative of Pol m (44).
VH mutations in Pol m-overexpressing Ramos cells
Most independent mutations in Pol m-overexpressing Ramos
cells were single-nucleotide substitutions (109 out of 111;
98%), in accordance with reported SHM features. This is
consistent with a role for Pol m in the generation of somatic
mutations in the hypermutation domain. The transition/trans-
version ratio (Ts/Tv) in Pol m-overexpressing Ramos cells was
0.75 (Table 1), in contrast to the known preference for transi-
tions over transversions in SHM. The Ts/Tv ratio in our con-
trol (parental and vector-transduced) Ramos cells was even
more pronounced toward transversions, however, with a Ts/Tv
ratio of 0.46 (see Table 1).
Human Pol m overexpression influenced nucleotide target
selection in Ramos cells (Table 1 and 2). The majority of
mutations were found in C (59.6%) and G (36.8%) residues,
rather than in A/T residues (3.6%); this nucleotide-targeting
preference was similar to that showed by our control (parental
and vector-transduced) Ramos cells, although more pro-
nounced. Detailed analysis of the mutational spectra obtained
following the Pol m overexpression (Table 2) showed that
C!G transversion dominated (34%), followed by C!T
transition (23%); the least frequent point mutations corres-
ponded to T!C transition and T!A transversion (1% each).
Figure 3 shows a summary of the nucleotide sequences
surrounding the residues targeted by the hypermutator machin-
ery in control and Pol m-overexpressing Ramos cells. Data
analysis indicated that the sequences most frequently mutated
in Pol m-overexpressing cells (nucleotide positions 66, 74, 156
and 218) and the mutations introduced exactly matched those
in control Ramos cells. Many control cell-derived mutations
were also represented in sequences from Pol m-overexpressing
Ramos cells (Figure 3). The analysis also showed good cor-
relation between point mutations and consensus RGYW/
WRCY motifs (indicated with boxes in Figure 3), predicted
as mutational hotspots in the SHM process. Both control and
Pol m-overexpressing Ramos cells showed hotspot mutability,
with about 45% of mutations targeted to these consensus
motifs, concurring with previous reports (16).
It could be inferred that Pol m overexpression in Ramos cells
reinforces the C/G mutational efficiency of the constitutive
SHM machinery, regardless of whether the mutations are
embedded in a RGYW/WRCY motif. This would affect the
proportions of each individual mutation in the final spectrum
and mutate C/G residues at the same rate.
In vitro human Pol m activity on template-primer
structures from Ramos IgVH region is largely
compatible with the in vivo mutation spectrum
Purified recombinant human Pol m behaves as an error-prone
DNA-dependent DNA polymerase, acting as a strong mutator
(44,46,56). To test whether the biochemical features of human
Pol m are compatible with the mutation pattern in Pol m-
overproducing Ramos cells, we analyzed in vitro misin-
corporation by human Pol m on several template-primer
molecules representing natural sequences. Polymerization
substrates were selected according to mutational spectra from
Pol m-overexpressing Ramos cells, to generate a set of mole-
cules corresponding to the most frequent IgVH4–34 gene
mutational hotspots, irrespective of their inclusion in a
RGYW/WRCY consensus motif (nucleotide positions 66,
74, 156, 193, 210 and 218; see Figures 3 and 4). Template-
primer structures were obtained by hybridization of synthetic
oligonucleotides corresponding to the mutational hotspots,
such that the in vivo mutated nucleotide was presented either
as the first templating base (positions 66, 156, 193, 210 and
218; white letters on black background in Figure 4), or as the
first nucleotide to be inserted (position 74). Using a standard
in vitro DNA polymerization assay and appropriate oligo-
nucleotide primers, Pol m misincorporation was evaluated in
the presence of all complementary and non-complementary
dNTPs. Nucleotide position 74 was frequently mutated from
G to T (10 and 3 times in Pol m-overexpressing and control
Table 1. Analysis of SHM at the IgVH4–34 gene of control and Pol m-over-
producing Ramos cells
Control
Ramos
Pol m-overproducing
Ramos
Mutations 32 111
Total nt sequenced 27 962 34 782
Mutational frequency
(·103 · Mut · base1)
1.1 3.2
A/T mutated 21.9 3.6
G/C mutated 78.1 96.4
Ts/Tv 0.46 0.75
Table 2. Distribution of nucleotide substitutions in control and Pol m-over-
producing Ramos cells
A C G T Total
Control Ramos (n = 32)
A x 6.3 6.3
C x 40.6 9.4 50.0
G 9.4 x 18.7 28.1
T 6.3 6.3 3 x 15.6
Pol m-overproducing Ramos (n = 109)
A x 1.8 1.8
C 2.8 x 33.9 22.9 59.6
G 17.4 7.5 x 11.9 36.8
T 0.9 0.9 x 1.8
n, total number of mutations.
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Ramos cells, respectively; see Figure 3). Pol m was able to
introduce T in front of the template C, generating a C:T mis-
match that was subsequently extended to establish the in vivo
G!T transversion (Figure 4). This C:T mismatch occurs at a
concentration (2 mM) similar to that of the correct nucleotide.
A similar result was obtained when position 218 was tested as
template (Figure 4); in this case, the efficiency of the Pol m-
generated C:A mismatch was similar to that for correct C:G
base pair. After replication of the mutated strand, this mis-
insertion led to a C!T transition, as also observed (15 times)
in Pol m-overproducing Ramos cells. These preferred
mutations could be explained by a mechanism involving
Figure 3. Summary of mutations and their sequence context. The nucleotide
position of the mutated residues with reference to the IgVH4–34 gene is shown
at left for control and Pol m-overproducing Ramos cells. Sequences are
presented in the canonical 50 to 30 direction, and mutated residues are
indicated with white letters on a black background. RGYW/WRCY hotspot
motifs are enclosed in boxes. Total number of mutations (T) and specific base
substitution (Mut) at each position are also shown. Nucleotide substitutions that
can be explained by Pol m ability to promote/accept transient misalignments,
either via slippage-mediated dislocation (D) or by dNTP-stabilized distortion
(d) mechanisms, are indicated.
Figure 4. Human Pol m misincorporation analysis on template-primer
structures derived from IgV mutational hotspots. Sequences containing
various nucleotide positions mutated in the IgVH4–34 gene of Ramos cells
are presented in the canonical 50 to 30 direction, with the exception of position
74, whose sequence (in gray) corresponds to the complementary strand. The
number of mutations and base substitution for each position is indicated below
each sequence. Mutated residues are indicated with white letters on a black
background. Labeled oligonucleotide primers used are depicted as a line
marked with asterisk at the 50 end. RGYW/WRCY hotspot motifs are
indicated with boxes. Polymerization assays were carried out as described
in Materials and Methods, in the presence of the indicated concentrations of
each dNTP. After 30 min at 30C, primer extension was analyzed by 8 M urea/
PAGE and autoradiography.
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misalignment of the primer terminus to be paired to the
adjacent templating base, through a dislocation mechanism
originally described for Pol b [reviewed in (57)], and Pol m
(46). In addition to the changes introduced at positions 74 and
219, those at positions 22, 167 and 338 can be also explained
by such a mistemplating mechanism (see Figure 3).
When nucleotide position 193 was tested as template, the
preferred Pol m-generated mismatch was G:T. After one repli-
cation round, it originated the same single base substitution
(G!A transition; see Figure 3) detected in vivo (four times) in
Pol m-overexpressing Ramos cells. The preference for the G:T
mismatch can be explained if Pol m is also able to use the
adjacent template nucleotide (dA) without realignment of the
primer, favoring insertion of a T residue. A mechanism in
which template misalignment is stabilized by an incoming
dNTP was originally described for Pol b (58). A similar ‘mis-
incorporation’ preference was observed when position 210
was tested as template (Figure 4); in this case, the G!A
transition observed in vivo (four times) was also compatible
with a dNTP-stabilized transient misalignment event pro-
moted by Pol m in vitro. In addition to the changes introduced
at positions 193 and 210, those at positions 52, 81, 86, 134,
143, 189, 216, 231, 237, 240, 254, 256, 288, 290, 293, 301, 311
and 324 can be also explained by such a mistemplating
mechanism (Figure 3).
When position 156 was tested as template, Pol m generated
the C:C mismatch (Figure 4), which resulted in a C!G
transversion like that obtained (15 times) in vivo in Pol
m-overexpressing Ramos cells after one replication round.
In this case, however, a higher concentration of non-
complementary dNTPs (50 mM) was necessary, and other
mismatches (C:T, C:A) were also generated. In contrast,
when position 66 was tested as template (Figure 4), no mis-
incorporation was observed in vitro, and the in vivo mutations
found at this position (14 C!G transversions; Figure 3) thus
could not be explained directly by the sole action of Pol m.
Pol m mutator ability is stimulated on DNA
strand break repair intermediates
Since single or double-strand breaks could be one of the initia-
tor events for the SHM mechanism, and assuming that Pol m
may have a role in DNA DSB repair (45–47), we examined
whether different substrates representing DNA repair inter-
mediates affected Pol m mutator ability in vitro. It is worth
noting that human Pol m, like other X family DNA poly-
merases (59–61), shows a marked preference for binding
DNA substrates that contain short gaps (J.F. and L.B., unpub-
lished results). We thus examined the mutational ability of
Pol m on nicked versus gapped (1 or 2 nt) DNA substrates
compared to DNA template-primer substrate.
Pol m used a nicked DNA substrate, preferentially inserting
the nucleotide complementary to the template base immedi-
ately adjacent to the nick (data not shown), which suggests
Pol m capacity for limited strand-displacement. Pol m inserted
the other 3 nt very poorly, indicating that nicked DNA is
a poor substrate for Pol m mutagenesis compared to the
template/primer, in which several templating bases are
available (unpaired).
When position 74, previously described as a mutational
hotspot in Pol m-overexpressing Ramos cells, was evaluated
in a 1 nt gapped DNA substrate (Figure 5A), Pol m preferen-
tially inserted the nucleotide (dG) complementary to the only
available templating base (C), although it was also able to
insert dT at the same nucleotide concentration (10–20 nM).
As for template/primer sequences, this ‘mismatch specificity’
can be explained by a slippage-mediated dislocation mechan-
ism, in which the next adjacent base (dA) can be used for
templating dT insertion (see the scheme at Figure 5A). In this
case, availability of the adjacent base as template implies
minimal displacement of the downstream DNA strand.
After realignment and potential ligation of the mismatched
terminus to the downstream strand, the G!T base substitution
would be established at position 74.
When position 74 was tested in a 2 nt gapped substrate
(Figure 5B), two bases were available for templating the
first insertion, with no strand displacement required. The tem-
plate misalignment potential of Pol m was thus enhanced on
this substrate, since incorporation of the non-complementary
dTTP was even more efficient than that of the complementary
nucleotide. As depicted in the scheme at Figure 5B, immediate
ligation of this dislocation intermediate after TMP insertion
would lead to a frameshift mutation, concurring with previous
speculations (46). A second insertion event leading to a +2
product was readily obtained with dTTP alone, however, sug-
gesting that the dislocation event is transient. After primer
realignment, formation of a new A:T pair would establish
the C:T mismatch as a single base substitution, precluding
formation of a 1 frameshift product. It is also possible
that, after template realignment and mismatch formation,
a mismatch-extender DNA poymerase such as Pol z, (62)
could enhance the reaction. A final ligation step, implying a
matched primer terminus, would generate the base substitution
seen in in vivo experiments.
When position 193 was tested as template in gapped-DNA
substrates (see Figure 6A and B), the preferred Pol m-catalyzed
misincorporation observed (G:T) was compatible with the
G!A transition found in Pol m-overproducing Ramos cells.
This specificity again supports a mistemplating mutation
mechanism that does not require template iteration, since
the distortion in the template strand is favored/maintained
by an incoming nucleotide complementary to an adjacent
templating base (see schemes at Figure 6), and may
(1nt-gap; Figure 6A) or may not (2 nt gap; Figure 6B) require
strand displacement. Template distortion is also sufficiently
transient in this case to allow creation of a G:T mismatch that
can be further elongated (in the case of the 2 nt gap) to avoid
the formation of a 1 frameshift product.
DISCUSSION
Human DNA Pol m is a recently identified DNA polymerase of
the mammalian Pol X family, closely related to TdT (44).
Recombinant purified Pol m nonetheless has intrinsic biochem-
ical properties differentiable from those of TdT; thus, although
Pol m shows mild terminal transferase activity, its catalytic
polymerization efficiency is strongly enhanced by the presence
of a template strand (44). Pol m and TdT also differ in their
expression patterns: while TdT expression is specifically
restricted to primary lymphoid tissues, Pol m mRNA expres-
sion is preferentially associated to secondary lymphoid tissues
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(44). Here, we confirmed this preferential expression at the
protein level, showing association of human Pol m to tonsil-
derived GC-B cells. Moreover, Pol m is localized entirely in
the nuclear compartment of purified human centroblasts, form-
ing foci-like structures very similar to those formed by several
DNA repair proteins in response to DNA damage (53–55).
Pol m was proposed to be part of the cellular response to DNA
DSB, because it directly interacts with protein factors involved
in the end joining pathway, and it forms nuclear foci which
coincide with those formed by gH2AX histone (47). However,
the Pol m foci observed in Ramos, as those observed in sorted
centroblasts (this manuscript) do not require exogenous
damage suggesting a more specific role of Pol m in processes,
as SHM, that could correlate with the appearance of specific
(targeted) DSBs. In agreement with Pol m participation in
SHM, murine Pol m expression is up-regulated in response
to immunization, and Pol m protein is found in GC that
developed in immunized spleen (D. Lucas, M. T. Lain,
M. A. Gonzalez, O. Dominguez, J. F. Ruiz, J. Chamorro,
C. Martinez-A, L. Blanco and A. Bernad, manuscript
submitted).
Pol m activity could contribute to the SHM process
As shown in this paper, human Pol m overexpression in an
in vivo system that recreates the SHM process, such as the
Figure 5. Pol mmisincorporation analysis at gapped-DNA intermediates containing position 74. DNA substrates in which position 74 is embedded in gaps of 1 nt (A)
or 2 nt (B) were obtained as described in Materials and Methods. Labeled oligonucleotide primers are shown in gray letters. The WRCY hotspot motif sequence
containing position 74 (arrow) is indicated with white letters. Templating residues available at each step are indicated with white letters on black background.
Polymerization assays were carried out as described in Materials and Methods, in the presence of the indicated concentrations of each individual dNTP. After 30 min
at 30C, primer extension was analyzed by 8 M urea/PAGE and autoradiography. Mobility of the unextended primer is indicated with an asterisk at the left of the
autoradiograph. A scheme detailing the different stages of the slippage-mediated dislocation model that explains the main misincorporation is shown (see text for
further details). Transiently misaligned nucleotides generated by dislocation or strand displacement are indicated with white letters on black circles. Mismatched
nucleotides are indicated with unfilled letters.
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Burkitt’s lymphoma-derived Ramos cell line, did not alter cell
viability and physiology parameters, but increased the muta-
tional rate at IgVH regions of Ramos cells (2.8-fold compared
to control cells). This effect was specific of IgVH genes, as no
mutations were detected in the of IgM locus constant region
(Cm), and IgM surface expression was unaffected. Mutations
in Pol m-overexpressing cells were mainly base substitutions,
targeted preferentially to C and G residues (94% of all
mutations detected). This indicates that human Pol m
overexpression enhances the previously reported natural
bias (16), increasing mutation at G/C residues. In contrast
to our data, TdT overexpression in Ramos cells did not
increase base substitutions, but significantly affected the
membrane IgM expression as a consequence of untemplated
nucleotide insertions at DNA breaks scattered throughout the
IgV domain (16).
In accordance with the mutation spectra from the Ramos
in vivo model, analysis of Pol m polymerization activity on
hotspot-containing DNA substrates supported the Pol m ability
to generate the same specific mutations in vitro. Biochemical
analysis showed that Pol m mutational specificity is dictated
largely by the sequence context; whereas a single-nucleotide
repeat is sufficient to induce slippage-mediated template mis-
alignment (dislocation), as reported by Zhang et al. (46), other
sequence contexts are less predictable, but effectively trigger
misalignments. As shown here for positions 193 and 210,
and for other non-specific sequence contexts (data not
shown), Pol m can promote mutations based on a dNTP
Figure 6. Pol mmisincorporation analysis at gapped-DNA intermediates containing position 193. DNA substrates in which position 193 is embedded in gaps of 1 nt
(A) or 2 nt (B) were obtained as described in Materials and Methods. Labeled oligonucleotide primers are shown in gray letters. The RGYW hotspot motif sequence
containing position 193 (arrow), is indicated in white letters. Templating residues available at each step are indicated in white letters on black background.
Polymerization assays and primer extension analysis were as in Figure 5. Mobility of the unextended primer is indicated with an asterisk at the left of the
autoradiograph. A scheme is shown detailing the different stages of the dNTP-stabilization-mediated model that explains the main misincorporation observed is
shown (see text for further details). Transiently misaligned nucleotides generated by dNTP-stabilized distortion or strand displacement are indicated with white
letters on black circles. Mismatched nucleotides are indicated with unfilled letters.
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stabilization-mediated mechanism of template misalignment
(58). Based on its dislocation capacity, a simplistic model was
proposed, in which Pol m would promote mainly frameshift
mutations rather than base substitutions, as an argument
against a role of Pol m in SHM (46). Our data indicate that
in vivo or in vitro Pol m-dependent mutations led preferentially
to single-nucleotide substitutions. This suggests that Pol
m-induced template distortions are transient, leading to the
mismatched pairs responsible for the base substitutions.
Moreover, Pol m mutational abilities are greatly enhanced
on gapped DNA substrates, concurring with a ‘DNA repair’
model that fixes certain mutations throughout the SHM
process.
These findings support a potential role for Pol m in the
physiological SHM process acting preferentially by promoting
mutation on G/C base pairs in the course of error-prone DNA
breaks-mediated repair.
How many polymerases contribute to SHM?
Considering all mechanistic evidences, a plausible model for
SHM envisions formation of programmed DNA breaks
(single- or double-strand breaks) in the hypermutation domain
of the Ig locus, to recruit several unique DNA polymerases
(Poli, Pol m, Polh, mutator polymerases, and Pol z, mismatch-
extender polymerase) that could act in concert for the error-
prone repair of initial or further-processed lesions (after
exonucleolytic action). The notion that multiple DNA poly-
merases are involved in SHM has been previously proposed by
several groups (29,30,43). However, the preferential partici-
pation of any of the DNA polymerases involved would be
determined by the nature of the initiating lesion, or controlled
by other proteins responsible for their specific recruitment.
The final output of the reaction would be conditioned by
the biochemical properties of each enzyme and the sequence
context in which it can act. This concurs with evidence for the
existence of two distinct mutators or mutational phases, one
directed to A/T residues and other to G/C residues (63).
Indeed, it was suggested that Pol h promotes A/T mutations
during SHM (7,36,64), and here we show that Pol m would act
preferentially on G/C residues, as also proposed for Pol i (39).
Finally, after resolution and ligation, several cellular repair
systems could allow fixation of some of the mutations intro-
duced, erasing others. Mouse knockout models analyses were
expected to provide a definitive answer to the putative indi-
vidual roles of the various DNA polymerases involved in
SHM. Nonetheless, homozygous knockout mice for the Pol
z gene suffer early embryonic lethality (65–67), and direct
analysis of its role in Ig SHM remains unevaluated. Moreover,
analyses of Pol m [(48); D. Lucas, M. T. Lain, M. A. Gonzalez,
O. Dominguez, J. F. Ruiz, J. Chamorro, C. Martinez-A,
L. Blanco and A. Bernad, manuscript submitted] and Pol i
(40) homozygous knockout mice show no gross defect in the
hypermutation mechanism. It is thus possible that the lack of
an SHM-deficient phenotype is due to redundancy among the
specialized DNA polymerases for the short gap-filling highly
error-prone DNA synthesis that seems to be linked to SHM
process. Further analyses, including generation of double or
multiple knockout mice, are needed to define the contribution
of Pol m and the other error-prone DNA polymerases to the
SHM process.
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